NCT00535912View on ClinicalTrials.gov

Phase III Study Treatment of CLL B and C

PHASE3CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

January 31, 1999

Study Completion Date

March 31, 2006

Conditions
Leukemia, Lymphocytic, Chronic
Interventions
PROCEDURE

Stem cells autograft

Treatment by Intensive Chemotherapy and autograft

All Listed Sponsors
lead

French Innovative Leukemia Organisation

OTHER

NCT00535912 - Phase III Study Treatment of CLL B and C | Biotech Hunter | Biotech Hunter